Dofetilide IV (Hyloris Pharmaceuticals)

N/A

Report date: 2024/03/22 11:34:58

Base Information

Drug NameDofetilide IV (Hyloris Pharmaceuticals)
Drug Alias NameIntravenous Dofetilide (Hyloris Pharmaceuticals)HY-CVS-033
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated potassium channel blockersPotassium channel blockers
TargetsVoltage-gated potassium channelPotassium channel
Therapy Area/IndicationsAtrial Fibrillation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHyloris Pharmaceuticals SA
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAtrial Fibrillation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A